Latest analyst takes
GenExDividendInvestorBULLABBV is presented as another case where the dividend barbell framework can work by combining income focus with growth outcomes (again dependent on purchase timing and duration).9d agoGenExDividendInvestorBULLAbbVie (ABBV) is a solid dividend holding for me (about $6,400 per year from ~$194k), reflecting my preference for companies that can keep rewarding shareholders.16d ago"ABBV is presented as another case where the dividend barbell framework can work by combining income focus with growth outcomes (again dependent on purchase timing and duration)."
"AbbVie (ABBV) is a solid dividend holding for me (about $6,400 per year from ~$194k), reflecting my preference for companies that can keep rewarding shareholders."